The effects of the therapeutic agents ponatinib and VS-5584 on caspase-3 activation in chronic myeloid leukemia


KAYABAŞI Ç., ÖZMEN YELKEN B., AŞIK A., BALCI T., SÖĞÜTLÜ F., GASIMLI R., et al.

4th Aegean Hematology Oncology Symposium, 21 - 24 Eylül 2017